Breaking Canadian GLP-1 news
GLP-1 News — Page 3
Drug approvals, price changes, generic timelines, and clinical trial results affecting GLP-1 medication costs in Canada.
Find my best option
Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.
BBC Profiles Ottawa Patient Paying C$350-C$500 Monthly for Wegovy
BBC profiles Ottawa retiree Elizabeth Doran, 69, who paid C$350-C$500 monthly out of pocket for Wegovy and took substitute teaching shifts to afford it.
BBC: US Patients Eye Canadian Generic Semaglutide as Prices Diverge
BBC reports Americans may look north for generic semaglutide as Canadian patients access generics priced at less than a third of brand cost.
Selectpath Urges Plan Sponsors to Mandate Generic Substitution
Selectpath advisor warns Canadian plan sponsors that lower generic semaglutide prices may not cut total spend without mandatory substitution and tighter prior authorization.
Dr. Reddy's CEO Israeli Frames Canada Launch as Access Mission
Dr. Reddy's CEO Erez Israeli says the company remains dedicated to expanding GLP-1 access in Canada after becoming first to win generic semaglutide approval.
Alberta Blue Cross 2026 Pipeline: GLP-1 'Second Wave' Coming
Alberta Blue Cross's 2026 drug pipeline report flags a second wave of GLP-1 innovation, with MASH and sleep apnea indications keeping plan spend high.
Novo Nordisk: More Than 1 Million Canadians Take Semaglutide
Novo Nordisk says more than a million Canadians take a semaglutide drug, as CGPA reports 500+ generic submissions under Health Canada review with 100+ backlogged.
Health Canada Notice: Seven More Generic Semaglutide Files in Queue
After Apotex became Canada's second generic semaglutide approval on May 1, seven additional generic semaglutide submissions remain under review at Health Canada.
Rexall, Shoppers Expect Generic Semaglutide Shipments This Week
Rexall expects a generic semaglutide shipment by week's end and Shoppers Drug Mart says inventory is arriving at distribution centres and select stores.
Novo Nordisk Savings Card Routes Ozempic Discount Through Rexall
Novo Nordisk Canada's reduced Ozempic price for uninsured patients launches via a Savings Card applied automatically at Novo Nordisk Care Rx by Rexall, excluding Quebec.
Health Canada Hit 180-Day Generic Target 84% of Time in FY25
Health Canada met its 180-day generic review target 84% of the time in fiscal 2024-25 as 500+ submissions sit under review, including seven semaglutide files.
Novo Nordisk Cites 9,650-Patient SOUL Trial Behind Rybelsus Nod
Novo Nordisk's Rybelsus MACE indication in Canada is backed by the 9,650-patient SOUL trial, with President Vince Lamanna calling it an important milestone.
CDA Benchmarks Mounjaro to Ozempic's $228 List Price in Canada
Canada's Drug Agency suggests public plans pay no more for 5 mg Mounjaro than the $228 list price of 1 mg Ozempic, with 25-49% discounts at higher doses.
Obesity Canada Cites $27.6B Untreated Cost in Coverage Pivot
Obesity Canada's Sockalingam ties the $27.6B 2023 untreated-obesity cost and sub-20% private-plan coverage to Canada's G7-first generic semaglutide approval.
Saskatchewan Blue Cross: Generic Semaglutide Doesn't Change Plan Rules
Saskatchewan Blue Cross says coverage rules for semaglutide are not changing after Health Canada's G7-first generic approval, though out-of-pocket costs may fall.
Apotex 2 mg and 4 mg Pens Set to Hit Alberta Shelves 'Any Day'
Apotex told CBC its 2 mg and 4 mg pre-filled generic semaglutide pens will reach Alberta pharmacies 'any day', with stock orders starting this week.
Alberta Pharmacies Begin Ordering Generic Semaglutide This Week
Calgary pharmacist Wessam Sakr was notified he could start ordering generic semaglutide this week, with Apotex pens expected on Alberta shelves any day.
Walk-In Maps Patent Timeline Behind Canada's G7-First Generic
Walk-In Clinic details the 2020 patent lapse, January 2026 data exclusivity end, and March 2026 formulation patent expiry that opened Canada's generic semaglutide path.
CDA Mounjaro Math: Lilly's $300 Floor Meets a 25-49% Discount Ask
Canada's Drug Agency wants 25-49% off higher-dose Mounjaro list prices, even after Eli Lilly's December cut set 2.5 and 5 mg at $300 for four weeks.
BMJ: Canada Is Only the Second Country to Clear Generic Semaglutide
BMJ reports Canada is only the second country in the world to approve a generic semaglutide, with two products cleared and seven more under Health Canada review.
Health Canada Details DIN Checks, CBSA Role in GLP-1 Advisory
Health Canada's January 21 advisory tells buyers to verify GLP-1 drugs via eight-digit DIN and Drug Product Database, and flags CBSA cooperation on shipments.
Looking for current pharmacy prices?
Compare GLP-1 prices across Canada